National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Viral hemorrhagic fever




The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.
orphanet

Orpha Number: 341

Definition
Viral hemorrhagic fever is a group of recently discovered contagious viral infections characterized by severe, multiple, and often fatal hemorrhages. African fevers include Lassa fever discovered in 1969, Marburg's disease that first occurred in 1967, and Ebola fever that appeared in 1976. Other viruses may also cause hemorrhagic fevers (for example, arbovirus fever).

Clinical description
Regarding Lassa fever, after a 7-day incubation period, fever and ulcerating hemorrhagic pharyngitis occur, followed by pleuropneumonia. The disease then progresses to either spontaneous cure or to profuse digestive or pulmonary bleeding that leads to death in 35 to 70% of cases. Transmission of Ebola between humans occurs mainly via direct contact with the disease or with infected biological products, rather than by the air-borne route. Clinical manifestations appear after a 4-16 day incubation period, initially with fever, cephalalgia, myalgia and conjunctival suffusion. Digestive symptoms then appear, including nausea, vomiting, and diarrhea, and are associated with leuco-thrombocytopenia. The next stage is marked by hemorrhage in the nose, intestines or genitalia. Biological findings include an isolated elevation of transaminases and stigmatas of disseminated intravascular coagulation. The disease is usually fatal within a few days.

Etiology
The reservoir for Lassa fever is a rodent which transmits the virus to humans directly, with no need of a vector. Ebola and Marburg viruses belong to the filoviridae viral family, but their reservoirs remain unknown. The source of the first documented Marburg epidemic was a group of African green monkeys imported from Uganda. Ebola virus causes deadly localized epidemics centered around central Africa.

Management and treatment
Treatment is symptomatic. Secondary prevention within hospital services consists of the total isolation of affected patients. The disease is notifiable.

Visit the Orphanet disease page for more resources.
Last updated: 8/1/2006

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 24 |
Medical Terms Other Names
Learn More:
HPO ID
80%-99% of people have these symptoms
Fatigue
Tired
Tiredness
[ more ]
0012378
Fever 0001945
30%-79% of people have these symptoms
Abdominal pain
Pain in stomach
Stomach pain
[ more ]
0002027
Arthralgia
Joint pain
0002829
Chest pain 0100749
Decreased liver function
Liver dysfunction
0001410
Diarrhea
Watery stool
0002014
Epistaxis
Bloody nose
Frequent nosebleeds
Nose bleed
Nose bleeding
Nosebleed
[ more ]
0000421
Gastrointestinal hemorrhage
Gastrointestinal bleeding
0002239
Gingival bleeding
Bleeding gums
0000225
Leukopenia
Decreased blood leukocyte number
Low white blood cell count
[ more ]
0001882
Migraine
Intermittent migraine headaches
Migraine headache
Migraine headaches
[ more ]
0002076
Myalgia
Muscle ache
Muscle pain
[ more ]
0003326
Nausea and vomiting 0002017
Skin rash 0000988
Spontaneous abortion 0005268
Subcutaneous hemorrhage
Bleeding below the skin
0001933
Thrombocytopenia
Low platelet count
0001873
5%-29% of people have these symptoms
Encephalitis
Brain inflammation
0002383
Hearing impairment
Deafness
Hearing defect
[ more ]
0000365
Recurrent bronchiolitis 0100501
Reduced consciousness/confusion
Disturbances of consciousness
Lowered consciousness
[ more ]
0004372
Retrobulbar optic neuritis 0100654
Seizure 0001250
Showing of 24 |
Last updated: 7/1/2020

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Clinical Research Resources

  • ClinicalTrials.gov lists trials that are related to Viral hemorrhagic fever. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

    Please note: Studies listed on the ClinicalTrials.gov website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

  • Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.